Brief: Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses
26/03/2025 12:02
March 26 (Reuters) - Salarius Pharmaceuticals Inc SLRX.O: SALARIUS PHARMACEUTICALS MERGER PARTNER, DECOY THERAPEUTICS, ANNOUNCES ITS NOVEL INHIBITORS SHOW PROMISING IN SILICO ACTIVITY AGAINST MEASLES AND RELATED VIRUSES Source text: ID:nGNX2Pm53f Further company coverage: SLRX.O ((Reuters.Briefs@thomsonreuters.com;))